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CEREBRAL BLOOD FLOW AND METABOLISM IN 
ANXIETY AND ANXIETY DISORDERS 
ROY J. MATHEW 
Anxiety disorders are some of the commonest psychiatric disorders and anxiety commonly co-exists 
with other psychiatric conditions. Anxiety can also be a normal emotion. Thus, study of the neuro-
biological effects of anxiety is of considerable significance. In the normal brain, cerebral blood flow 
(CBF) and metabolism (CMR) serve as indices of brain function. CBF/CMR research is expected to 
provide new insight into alterations in brain function in anxiety disorders and other psychiatric 
disorders. Possible associations between stress I anxiety I panic and cerebral ischemia I stroke give 
additional significance to the effects of anxiety on CBF. With the advent of non-invasive techniques, 
study of CBF/CMR in anxiety disorders became easier. A large numbers of research reports are 
available on the effects of stress, anxiety and panic on CBF/CMR in normals and anxiety disorder 
patients. This article reviews the available human research on this topic. 
Key words: cerebral blood flow, cerebral metabolism, anxiety, anxiety disorders, obsessive compulsive 
disorder, panic disorder, generalized anxiety disorder, sympathetic stimulation. 
INTRODUCTION 
The word anxiety means being troubled in mind 
about some uncertain event, being in disturbing 
suspense, being fraught with worry, etc. The inef-
fable feeling of foreboding is regarded as the central 
core. When the cause for the emotion is clear, the 
word fear is preferred. Anxiety as part of everyday 
experience, can be a normal emotion. But it can also 
be an abnormal one and distinctions between normal 
and abnormal are difficult. Operationally, abnormal 
anxiety has been identified as causing the sufferer to 
seek relief. Another distinction is based upon the 
relationship of the intensity / duration of the emotion 
to the apparent cause, abnormal anxiety being dis-
proportionately excessive. No qualitative differen-
ces have been demonstrated between normal and 
abnormal anxiety (Lader, 1982). Intensity of anxiety 
associated with a given situation is a function of the 
anxiety proneness of the individual and the degree 
of threat perceived by him/her. Anxiety disorders are 
some of the commonest psychiatric illnesses and 
they commonly co-exist with other physical and 
mental disorders. A number of disorders which dif-
fer in clinical characteristics have been subsumed 
under anxiety disorders (DSM-IIIR) 
RELEVANCE 
The relationship between anxiety and cerebral 
blood flow (CBF) is of considerable significance for 
a variety of reasons. As was pointed out earlier, 
anxiety disorders are some of the commonest 
psychiatric disorders and anxiety is present in almost 
all other psychiatric disorders (Kessler ct a I, 1985; 
Regier et al, 1988). Anxiety as a normal emotion is 
a part of day to day existence. Thus, understanding 
of the physiology of anxiety will be relevant to the 
entire field of psychiatry. 
Cerebral anoxia is the most important clinical 
manifestation of reduced CBF. Such symptoms as 
dizziness, unsteadiness, light headedness and faint-
ing (DSM IIIR) are often seen in anxiety disorder 
patients and may be indicative of cerebral anoxia. 
Blood pressure reduction via vasovagal mechanisms 
and consequent cerebral ischemia are commonly 
held responsible. However, alternate explanations 
are available and no firm conclusions are justified. 
In a study of nineteen patients with panic disorder 
and twenty six with generalized anxiety disorder, 
patients had a significantly higher prevalence of 
symptoms suggestive of cerebral ischemia as com-
pared to controls; 47% reported dizziness, 32% loss 
of speech, 37% tingling and 16% weakness and 
paralysis (Mathew et al, 1987). Among three 
hundred and fifty referrals to a neurology service, 
5% had panic attacks manifestingas focal neurologi-
cal symptoms lasting approximately fifteen to thirty 
minutes. All patients experienced, simultaneously 
two or three different neurological symptoms, in-
cluding sensory, motor, visual and vestibular 
symptoms and headache. The most frequent sensory 
symptom was numbness and tingling in a hemi-sen-
sory distribution or localized to one extremity. 
Motor symptoms included clumsiness or a feeling of 
heaviness of an extremity. Bilateral blurring or total 
blindness, often associated with visual distortions 
were seen. Hyperventilation which reduces CBF 
(Fried, 1987; Mathew & Wilson, 1988; Maximilian 
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et aL 1980) reproduced the specific symptoms in 
42% of the patients (Coyle & Sterman, 1986). Focal 
neurological symptoms indicate reduced regional 
(as opposed to global) CBF and argue against reduc-
tion in blood pressure vasovagal mechanisms 
(which is more likely to produce global CBF 
decrease). Reduction in global CBF usually results 
in dizziness and fainting but cannot explain focal 
neurologic symptoms in individuals with no pre-ex-
isting abnormalities of cerebral circulation. It should 
be noted that the patients studied by Mathew et al 
(1987) and Coyle and Sterman (1986) did not suffer 
from any neurological or circulatory disease. 
Anxiety disorder patients often complain of 
headaches. In all probability, tension headaches and 
anxiety are closely related; the relationships be-
tween vascular headaches and anxiety are less clear 
(Headache Classification Committee of the Interna-
tional Headache Society, 1988). A number of re-
search reports are available on intra and 
extra-cranial blood flow changes associated with 
various types of headaches (Olesen, 1991). Sym-
pathetic activation may play a causal role in at least 
certain types of headaches (Mathew et al, 1982a). 
Information regarding CBF changes associated with 
anxiety will give new insights into the vascular 
mechanisms related to headaches. 
Several case reports and epidemiologic studies 
identified stress and anxiety as risk factors for stroke 
(Adler et al, 1971; Leonbcrg & Elliott, 1978; 
Weissman et al, 1990). However, there usually listed 
among the established risk factors for stroke (Haber-
man et al, 1982) although their relationship to 
coronary artery disease is well accepted (Mathews 
et al, 1986). Coronary heart disease is a risk factor 
for stroke (Wolf et al, 1978). More research, both 
population studies and laboratory studies, need to be 
conducted on stress/anxiety and stroke. 
Stimulants and most hallucinogens induce sym-
pathetic activation (as in anxiety) manifested by 
increased pulse rate, blood pressure, respiration and 
perspiration. Most subjects do not experience this 
sympathetic activation as unpleasant; as a matter of 
fact, drug-induced sympathetic stimulation usually 
co-exists with euphoria (Mathew & Wilson, 1985a; 
Lake. 1988; Gawin & Ellinwood. 1988). However, 
less frequently, these drugs can produce anxiety and 
panic and such symptoms as restlessness, agitation, 
irritability, distractibility, etc (Charney et al, 1985, 
Gawin & Ellinwood, 1988, Anthony et al, 1989). 
Withdrawal from yet other drugs of abuse such as 
ethyl alcohol, benzodiazepines and barbiturates are 
associated with central and peripheral symptoms of 
sympathetic activation and anxiety (Hawley et al, 
1985; Mellman & Uhde, 1986; Foy et al, 1988; 
Thomas et al 1989, George et al, 1988). According 
to some investigators, stimulant intoxication and 
sedative (alcohol) withdrawal decrease CBF 
(Berglund et al, 1981, Mathew and Wilson, 1991). 
Drugs of abuse, especially stimulants and alcohol 
have also been implicated in the causation of 
cerebral ischemia and stroke (Caplan et al, 1982; 
Levine & Welch, 1987; Sloan et al, 1991, Mathew 
& Wilson, 1991). Cerebral blood vessels are inner-
vated by vasoconstrictive sympathetic fibers (Ed-
vinsson et al, 1993). Thus, the relationship between 
anxiety and CBF will be of importance to CBF 
changes during drug (sympathetic agonists) in-
toxication and (sedatives, hypnotics) withdrawal 
(Mathew & Wilson, 1991). 
MEASUREMENT TECHNIQUES 
Study of global and regional alterations in CBF 
became easier with the advent of less invasive meas-
urement techniques (Mathew et al, 1985). In the 
normal brain, CBF and Cerebral metabolism (CMR) 
serve as indices of brain function (Figure 1). Func-
tional psychiatric disorders are believed to be caused 
by abnormal brain function, which is the main 
reason why CBF and CMR are used in psychiatric 
research. Techniques such as the
 i Xenon intra-
carotid injection and inhalation techniques, Single 
Photon Emission Computed Tomography (SPECT) 
and Positron Emission Tomography (PET) measure 
CBF; PET can also be utilized for the quantification 
of CMR for glucose and oxygen (Mathew et al, 
1985; Mazziotta, 1985). 
These techniques vary in the degree of invasive-
ness with the intra-carotid
 i Xenon injection tech-
nique being the most invasive and therefore, the least 
utilized, at present. Invasiveness of the technique is 
very important especially in anxiety research, for 
obvious reasons. Quantification of absolute CBF 
with PET require arterial punctures (Mazziotta, 
1985). Arterial punctures induce varying degrees of 
anxiety in patients as well as normals and the sensa-
tion of pain, on its own right, might increase CBF 
(Ingvar & Lassen, 1976). Less invasive PET techni-
ques for CBF/CMR measurements are being 
developed. It is difficult to calculate absolute CBF 
with SPECT expect when
 13
3 Xenon is used as the 
tracer in which case spacial resolution is less impres-
sive. All of the above mentioned techniques have the 
disadvantage of the known and unknown risks as-
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sociated with radiation exposure. More recently, 
Magnetic Resonance Spectroscopic (MRS) techni-
ques which do not involve any radiation exposure 
have been developed for the measurement of CBF 
and CMR (Lock et al, 1990). Unfortunately, most of 
these MRS techniques do not provide absolute quan-
titation. MRS techniques have not been widely used 
in psychiatric research. 
Trans-Cranial Doppler (TCD) Sonography can 
be used to measure cerebral blood velocity (CBV) 
through major intracranial arteries (Aaslid et al, 
1982; Aaslid & Lindergaard, 1986). CBV is deter-
mined by the perfusion pressure (arterial blood pres-
sure minus venous pressure) and resistance to flow 
(intracranial pressure and cerebral vascular resis-
tance) in the brain. Thus, if the perfusion pressure 
Figure 1 
Energy Metabolism 
/^V^^__ I < •1000 FLOW- •  T=?/9fr94*, 
Cerebral blood flow and metabolic rates 
for glucose or oxygen may be used as 
indices of brain energy metabolism 
In the normal brain, blood flow and metabolism 
are closely coupled with brain function. 
Cerebral blood flow delivers glucose and 
oxygen to the brain and removes the meta-
bolites, carbon dioxide and water. Glucose 
and oxygen are directly related to the energy 
metabolism. 
and intracranial pressure are within normal limits 
with minimal fluctuations, CBV can serve as an 
index of CBF. However, TCD does not give infor-
mation about regional CBF. Its major advantages are 
absence of radiation exposure, total non-invasive-
ness, simplicity, ability to measure CBV in different 
positions (lying, sitting and standing) and ability to 
measure CBV every thirty seconds. The last feature 
will provide useful information about the dynamic 
changes in CBF especially after anxiety induction. 
TCD has been used to study the effects of 
psychotropic drugs on cerebral circulation (Mathew 
et al, 1992 a, b & c). 
PHYSIOLOGY 
A great deal of information is currently available 
on CBF physiology (Busija & Heistad, 1984 a; 
Mathew et al, 1986; Edvinsson et al, 1993). Anxiety 
is associated with many physiological changes a 
number of which may be relevant to CBF (Figure 2). 
Both central and peripheral factors related to anxiety 
can influence CBF. It is important to note that 
anxiety related CBF changes are most likely to be 
influenced by a variety of factors other than brain 
function. Although an impressive volume of basic 
science research has confirmed their relevance (Ed-
vinsson et al, 1993), unfortunately, factors other than 
brain function have not received the importance they 
deserve in contemporary, CBF/CMR research in 
psychiatry. Such factors are especially important in 
anxiety/CBF research. 
AROUSAL 
Nonspecific arousal is believed to be the neuro-
biologic substrate for anxiety (Lader, 1982; Moruzzi 
& Magoun, 1949; Malmo, 1959). The brain stem 
reticular activating system generates generalized, 
diffuse activation of the brain. Anxiety is associated 
with high levels of arousal while low arousal is 
associated with drowsiness, sleep and coma. Since 
CBF is closely coupled to brain function, CBF in-
crease will be expected in high arousal states and 
decrease, in low arousal states. Indeed, CBF reduc-
tions have been reported in semicoma, stupor and 
slow wave sleep; activation and epileptic seizures 
being associated with increased CBF (Townsend, 
1973; Ingvar and Lassen, 1976; Mathew, 1989; 
Mathew & Wilson, 1990; Mathew et al, 1993 c). 
The brain stem reticular activating system ter-
minates in the reticular nuclei of the thalamus from 
where cortical and other limbic connections 
originate (Nauta, 1971; Stuss & Benson, 1986; Feir-
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tag & Nauta, 1986). Thalarno-frontal connections 
are well known since these fibers are commonly 
interrupted in psycho-surgical techniques (Kelly, 
1986). The frontal lobe has been identified as the 
"cortical representative" of the arousal system. The 
well known EEG pattern of predominately high 
frequency / low voltage wave-forms over the frontal 
lobe during wakefulness lends support to the con-
cept of frontal activation during arousal (Ingvar, 
1979; Ingvar & Soderberg, 1958; Menon et al, 
1980). 
Most of the studies conducted with the intra-
carotid Xenon injection and Xenon inhalation 
studies found higher frontal flow during resting 
wakefulness (Ingvar, 1979; Mathew et al, 1986; 
Weinberger ct al, 1986; Mathew et al, 1988). How-
ever, more recent studies with the three dimensional 
CBF techniques (PET, SPECT) failed to replicate 
this finding (I>auritzen et al, 1981; Rapoport et al, 
1985; Devous et al, 1986). It is unclear whether this 
discrepancy is due to physiologic or technologic 
reasons (Mathew, 1989). 
Behavioral and pharmacological activation of the 
brain seems to augment frontal circulation. Techni-
ques used to increase activation include problem-
solving test, word-pair learning and recall, 
digit-span backward test and reasoning test, right-
left discrimination test, the Wisconsin Card Sort, 
sensory stimulation and a variety of attention-
demanding tasks (Risberg et al, 1977; Maximilian et 
al, 1978; Risberg & Ingvar, 1973; Leli et al, 1983; 
Risberg & Prohovnik, 1983; Weinberger et al, 1986; 
Deutsch et al, 1987a). It needs to be pointed out that 
some investigators could not find increased frontal 
flow during the administration of the Raven's 
progressive matrices and right-left discrimination 
test (Berman et al, 1988, Leli et al, 1982). Euphoria 
associated with marijuana increased global CBF 
with most marked changes in the frontal lobes. The 
CBF increase seen after marijuana smoking was 
unrelated to plasma THC and possibly, peripheral 
vasodilation (Mathew & Wilson, 1993). 
Studies have also been conducted on CBF during 
reduced arousal. Slow wave sleep attenuates frontal 
Figure 2 






HATCHED CIRCLES SHOW FACTORS OF GREATER SIGNIFICANCE. 
Sympath: sympathetic activation, Viscosity: blood viscosity, Arousal: non-specific arousal mediated by 
the reticular activating system, Catechol: catecholamines, Hypocarb: hypocarbia (hypocapnia), Hy-
perten: hypertension. 
Anxiety is associated with a number of factors which can influence CBF in either direction. Known 
factors, the directions of their effects and their relative importance are shown. 
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flow and hyperfrontality is absent in comatose states 
(Townsend et al, 1973; Deutsch & Eisenberg, 
1987b; Madsen & Vorstrup, 1991). Tranquilization 
induced with non-sedating doses of diazepam 
reduced frontal perfusion (Mathew et al, 1985). 
Similarly, haloperidol decreased global including 
neocortical CMR glucose, after twelve hours (Bar-
lettetaL1994). 
It seems safe to conclude that global CBF has a 
parallel relationship with arousal states. Most avail-
able studies but not all, suggest that arousal related 
CBF changes are most marked in the frontal lobe. 
HYPOCAPN1A 
Carbon dioxide is very well known as a potent 
cerebral vasodilator (Maximilian et al, 1980; Math-
ew & Wilson, 1988). Hyperventilation characterized 
by increased rate and depth of respiration and 
hypocapnia, is a common symptom of acute anxiety 
and panic (Fried, 1987). Hypocapnia in turn, can 
induce cerebral vasoconstriction. Indeed, CBF 
reduction due to reduced CO2 has been implicated 
in several anxiety related symptoms (Fried, 1987). 
As was pointed out earlier, hyperventilation can 
produce focal neurological symptoms suggestive of 
cerebral ischemia in panic disorder patients (Coyle 
and Sterman, 1986). Panic disorder patients may 
show an exaggerated CBF decrease during hyper-
ventilation (see below: Gibbs, 1992). 
AUTONOMIC NERVOUS SYSTEM 
A great deal of literature is available on the 
relationship between anxiety and autonomic nerv-
ous system activation (Lader, 1975). Such effects of 
acute anxiety on blood circulation as increased heart 
rate, increased blood pressure, reduced skin circula-
tion and increased muscle flow are due to stimula-
tion of the sympathetic division of the autonomic 
nervous system. Thus, sympathetic innervation of 
cerebral blood vessels can be of considerable sig-
nificance. 
Sympathetic nerve fibers reach cerebral blood 
vessels through three routes. Post-ganglionic fibers 
from the superior cervical ganglion innervate ves-
sels in the carotid territory. The vertebro-basilar 
territory is innervated by the stellate ganglion. Last-
ly, fibers from the stellate ganglion may follow the 
tunica adventitia of the common p.nd internal carotid 
arteries to reach the circle of Willis. There is progres-
sive reduction in the number of sympathetic fibers 
as the vessels become smaller; larger arteries which 
travel up through the brain tissue from brain-stem 
nuclei such as locus ceruleus can be found on or near 
cerebral microvessels (Edvinsson, 1982; Edvinsson 
et al, 1993). Cerebral blood vessels contain both 
alpha and beta adrenergic receptors (Nathanson, 
1983). The sympathetic fibers also influence CMR, 
blood brain barrier permeability and CBF produc-
tion (Edvinsson et al, 1993). 
LESS RELEVANT FACTORS 
Other anxiety related physiological changes such 
as an increase in the blood levels of epinephrine and 
norepinephrine and changes in blood viscosity are 
unlikely to be very relevant. Peripheral epinephrine 
and norepinephrine are destroyed by the blood brain 
barrier which contain such enzymes as monoamine 
oxidase (MAO) and catechol O methyl transferase 
(COMT) (Edvinsson & MacKenzie, 1976; Mac-
Kenzie & Scatton, 1987; Edvinsson et al, 1993). 
Anxiety related increase in blood viscosity (other-
wise known as stress polycytosis) seems to be too 
modest to influence CBF (Dameshek, 1953; Math-
ew & Wilson, 1986 & 1987). Anxiety related in-
creases in pulse rate and blood pressure are unlikely 
to be of relevance since CBF is insulated from 
modest changes in blood pressure (autoregulation) 
(Strandgaard & Paulson, 1984; Paulson et al, 
1990). 
CBF DURING UNPROVOKED ANXIETY 
Even non-invasive measurement of CBF can be 
stressful especially to lay individuals unaccustomed 
to hospitals and laboratories. Most measurement 
techniques involve sophisticated machinery which 
can induce apprehension. Anxiety associated with 
exposure to the measurement technique can vary 
from none to very severe. A number of investigators 
looked at the relationship between anxiety as-
sociated with the measurement technique and 
CBF/CMR. Mild to moderate degrees of anxiety 
caused CBF increase but more severe anxiety had 
the opposite effect. High anxiety also had a negative 
relationship with cerebral metabolism (Gur et al, 
1987; Rodriguez et al, 1989). 
The first CBF measurement will be expected to 
produce more anxiety than the second and their 
measurements. In normal volunteers, when CBF 
was measured repeatedly during rest, values 
decreased from the first to the second measurement. 
This CBF decrease was most marked in the frontal 
regions (Warach et al, 1992). Gur and colleagues 
(1987) found a positive relationship between CBF 
and anxiety when the anxiety was mild. However, 
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with more severe anxiety, CBF declined. Rodriguez 
and associates found an inverse correlation between 
CBF and state anxiety in sixty neurologically normal 
patients. These inverse correlations were mosi sig-
nificant in the right frontal region. 
Other investigators exam ined the relationship be-
tween anxiety during the measurement of CMR with 
PET. Reivich and associates (1983) found a cur-
vilinear relationship between fronto-cortical meta-
bolism and anxiety. However, anxiety during 
measurement of CMR glucose was found to have no 
effect by Giordani and colleagues (1990). Other 
investigators also found minimal or no relationships 
between CMR and anxiety associated with the pro-
cedure (Duara et aL 1984; Buchsbaum et al, 1985). 
Anxiety disorder patients who are more anxiety 
prone are likely to experience more anxiety during 
the procedure than normal volunteers. Studies on the 
relationships between anxiety and resting 
CBF/CMR have been conducted in patients with 
generalized anxiety disorder (GAD), obsessive 
compulsive disorder (OCD) and panic disorder. In 
patients with generalized anxiety disorder, state 
anxiety and CBF showed an inverse correlation 
(Mathew et al, 1982). Anxiety in OCD patients also 
significantly correlated inversely with CBF 
(Machlin et al, 1991). In another study of OCD 
patients, state anxiety during CMR measurement 
with PET correlated significantly with right prefron-
tal, left prefrontal and right orbital CMR (expressed 
as ratios to the mean cortical CMR). OCD patients 
who panicked showed significantly lower left 
premotor and higher right prefrontal CMR (Swedo 
etal, 1987). 
It is well known that many but not all, panic 
disorder patients experience panic attacks during 
lactate infusions. In lactate sensitive panic disorder 
patients, under resting conditions, a significantly 
lower right to left ratio in the parahippocampal gyrus 
blood flow in comparison to the lactate insensitive 
panic disorder patients and normals was found 
(Reiman, 1984). Lactate sensitive patients also had 
abnormal asymmetries of parahippocampal blood 
volume and metabolic rate for oxygen. Analysis of 
parahippocampal measurements on each side 
separately suggested an abnormal CBF increase in 
the right side in lactate sensitive panic disorder 
patients. They also showed a significantly higher 
whole brain metabolic rate for oxygen (Reiman et 
aL1986). 
Nordhal and associates (1990) conducted a 
similar study. Panic disorder patients, during 
auditory discrimination tests were found to show 
asymmetry of CMR glucose in the hippocampus; 
however, they did not show any abnormalities of 
global grey matter metabolism. 
In summary, it seems fairly clear the mild anxiety 
is associated with CBF increase. Higher CBF during 
the first as compared to the second CBF measure-
ment is well established and it provides firm support 
for this notion. It is possible that more severe anxiety 
decreases CBF. Under resting conditions, frontal 
CBF is higher than the rest of the brain and during 
repeated measurement, frontal CBF shows most 
marked reduction. There are only few studies on 
regional CBF/CMR in panic disorder patients, under 
resting conditions. Available literature suggests 
asymmetry of CBF/CMR in the hippocam-
paVparahippocampal region. 
There are only few studies on CMR and resting 
levels of anxiety. Of the available studies in panic 
disorder and OCD, results vary widely. Thus, effect 
of resting anxiety on CMR is less certain. 
ACTIVATION STUDIES IN NORMALS 
Several investigators utilized specific strategies 
to induce stress in normal volunteers. Techniques 
used included mental arithmetic tasks (Sokoloff et 
al, 1955) and speaking and counting (Shakhnovich 
et al, 1980). It should be noted that brain function 
and CBF are coupled and therefore, perception of 
the sensory stimulation associated with the stress 
inducing task on its on right, should increase CBF in 
the corresponding brain regions. In earlier studies 
which measured global flow with no separation be-
tween grey and white matter flow, no CBF changes 
were seen during sensory stimulation associated 
with stressful tasks. More modern techniques which 
separated brain regions and grey from white matter 
showed CBF increase in sensory regions and in-
crease in global flow during activation studies (Ris-
berg et al, 1977; Maximilian et al, 1978; Risberg and 
Ingvar, 1973; Lelietal 1983; Weinberger etal, 1986; 
Risberg & Prohovnik, 1983; Deutsch et al, 1987). 
Most investigators did not report degrees of anxiety 
during the procedures. 
CBF DURING PHARMACOLOGICALLY 
PROVOKED ANXIETY 
A wide variety of pharmacological techniques 
were utilized to examine the relationship between 
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induced anxiety and CBF. Caffeine is well known to 
induce anxiety in normal subjects, anxiety disorder 
patients and especially, those with panic attacks 
(Charney et al, 1985; Gorman, 1987). Caffeine is a 
powerful cerebral vasoconstrictor (Mathew & Wil-
son, 1985b). However, intravenous administration 
of 250 milligrams of caffeine did not induce anxiety 
in GAD patients and there were no significant dif-
ference between GAD patients and normals on caf-
feine induced cerebral vasoconstriction. (Mathew & 
Wilson, 1990). Epinephrine infusions on the other 
band, produced significant increases in state anxiety, 
respiration and pulse rate. However, there were no 
significant differences between GAD patients who 
received epinephrine and saline on hemispheric or 
regional CBF, though, in the epinephrine group, 
significant inverse correlations were found between 
state anxiety and left and right hemispheric CBF 
(Mathew et aL 1982b, Mathew & Wilson, 1989a). 
Carbon dioxide inhalation is another technique 
used by several investigators for anxiety induction, 
especially in panic disorder patients (Gorman, 
1987). As was mentioned earlier, CO2 is a powerful 
cerebral vasodilator (Maximilian et al, 1980). In our 
hands, CO2 inhalation did not induce more state 
anxiety in GAD patients as compared to controls. 
Both patients and controls showed similar cerebral 
vasodilation during 5% CO2 inhalation. However, 
some of the patients and controls reported increased 
anxiety during the procedure and those who showed 
anxiety increase also showed less marked increases 
in CBF. There was a significant inverse correlation 
between CBF and state anxiety for the entire group 
during CO2 inhalation. Thus, the results indicated 
that subjects who became anxious during 5% CO2 
inhalation showed less marked CBF increase (Math-
ew&Wilson 1988 & 1989b). This finding supported 
the notion of cerebral vasoconstriction during severe 
anxiety. 
Acetazolamide is known to inhibit carbonic an-
hydrase which normally catalyzes the hydration of 
CO2 and hydrolysis of carbonic acid. Thus, 
acetazolamide injections result in hypercapnia. 
Panic disorder patients who received intravenous 
injections of acetazolamide did not develop panic 
attacks. However, both panic disorder patients and 
normals after the drug, snowed significant CBF in-
creases. Once again some of the subjects from the 
panic disorder group and normal controls reported 
increased anxiety after the injection and those who 
became anxious showed less marked cerebral 
vasodilation (Mathew et al, 1989). 
Although carbon dioxide inhalation is reported to 
precipitate anxiety, hyperventilation and hypocap-
nia have also been found to cause panic attacks 
(Gorman et al, 1988; Maddock & Carter, 1991). It is 
possible that the distress caused by both hyper and 
hypocapnia precipitates panic in predisposed 
patients. 
Gibbs (1992) examined cerebral blood velocity 
(CBV) of the basilar artery with TCD in nine panic 
disorder patients and nine controls, both under rest-
ing conditions as well as during hyperventilation. 
Panic disorder patients showed more marked 
decrease (62%) as compared to the controls (36%). 
It is conceivable that the patients experienced more 
anxiety than the controls and therefore, it may be 
argued that the more marked decrease in CBV in 
patients may be due to anxiety related cerebral 
vasoconstriction. Unfortunately, the investigators 
did not report levels of state anxiety and CO2 and no 
firm conclusions are possible (Mathew, 1993). 
Lactate infusion is a well known panic inducting 
technique (Gorman, 1987). Lactate also reduces 
brain P^ and increases CBF. Reiman and associates 
(1989) found significant increases in CBFbilaterally 
in temporo-frontal cortex, bilaterally in the insular 
cortex and the claustrum, bilaterally in or near the 
superior colliculus, and in or near the left anterior 
cerebellar vermis during lactate infusion in panic 
disorder patients. Lactate infusion was not as-
sociated with significant changes of regional CBF in 
non-panicking patients or normals. However, in 
another study, panic disorder patients who panicked 
during lactate infusions showed smaller increases or 
decreases in CBF as compared to the others (Stewart 
et al, 1988). Yohimbine is also known to precipitate 
panic attacks in predisposed individuals. Yohimbine 
decreased bilateral frontal cortical blood follow 
(relative to the rest of the brain) consistently, in 
comparison to a placebo, in panic disorder patients 
but not in control subjects (Woods et aL 1988). 
Most studies on pharmacologically induced 
anxiety showed reduced CBF with severe anxiety. 
Regional variations in the cerebral vasoconstriction 
related to severe anxiety are unclear. 
EXPOSURE OF PHOBIC OBJECTS 
Behavioral techniques for anxiety induction rep-
resent 'cleaner' anxiety induction. Exposing 
patients with phobias to the fear inducing object or 
situation would seem to be an effective anxiety 
inducing behavioral technique. In one such study, 
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patients with 'contamination fear' were exposed to 
a contamination object through imageries and in 
vitro exposure. In vitro exposure was associated 
with significant decreases in global and regional 
flow values (Zohar et al, 1989). In another study on 
female patients with animal phobia, patients were 
exposed to the phobic object. Patients showed lower 
CBF values when they were exposed to the phobic 
object although the difference did not reach statisti-
cal significance (Mountz et al, 1989). 
Other investigators (Wik et al, 1993) measured 
CBF with PET in volunteers with snake phobia 
during exposure to the phobic object. The vis-ial 
stim ulation presumably increased CBF in the occipi-
tal cortex (sensory stimulation?) but flow was 
reduced in the hippocampus, orbito-frontal, prefron-
tal, temporal and posterior cingulate cortex. These 
studies also indicate an anxiety related cerebral 
vasoconstrictive factor. Once again, they do not 
provide any meaningful insights into regional varia-
tions. 
OTHER RELEVANT STUDIES 
CMR glucose measured with PET during dreams 
showed positive correlations with anxiety in lateral 
parietal and medial frontal cortex and negative cor-
relations in adjacent white matter (Gottschalk et aL 
1991). In another PET scan study of CMR glucose 
during an active vigilance task, activation of basal 
ganglia metabolism was seen. Benzodiazepine 
therapy resulted in reduced metabolism of cerebral 
cortex, limbic system and basal ganglia. Basal 
ganglia was identified as a brain region very relevant 
to anxiety (Wu et al, 1991). Yoga meditation did not 
produce any significant changes in CMR glucose; 
however, the frontal-occipital ratio significantly in-
creased suggesting increased frontal activation 
(Herzogetal, 1990). 
CBF/CMR IN OBSESSIVE COMPULSIVE 
DISORDER 
Functional brain imaging studies were performed 
by a number of investigators on patients with OCD. 
This line of investigation was complicated by a 
number of factors. Obsessive compulsive disorder 
has a wide variety of clinical manifestations. In 
addition, these patients vary in degrees of associated 
anxiety and depression. Some of the available 
studies focused primarily on regional as opposed to 
global CBFand CMR. Different imaging techniques 
were utilized and because of the differences in the 
data they produced, comparisons between studies 
were difficult. In spite of these difficulties, the in-
vestigators have come up with meaningful results 
which were replicated several times. Phobias are 
sometimes classified under obsessive compulsive 
disorder. CBF/CMR studies on phobic subjects were 
reviewed above. 
Several CBF studies in OCD were performed 
with HMPAO-SPECT. In one study, when ten non-
depressed, medication free OCD subjects were com-
pared to eight matched controls, patients had higher 
medial frontal flow. Anxiety in these patients sig-
nificantly correlated inversely with CBF (Machlin 
et al, 1991). Treatment with fluoxetine over three to 
four months showed decrease in medial frontal cor-
tical CBF (Hoehn-Saric et al, 1991). In another study 
with the same CBF measurement technique, patients 
showed increased flow to orbital cortex bilaterally, 
left postero-frontal cortex and bilateral high dorsal 
parietal cortex. CBF was decreased in the caudate 
133 
bilaterally. When CBF was measured with 
Xenon, increase in OCD symptoms produced by 
m-chloropheny lpiperazine (a serotonin agonist) cor-
related significantly with CBF, especially in the 
frontal lobes (Hollander et al, 1991). 
Studies of CMR glucose in OCD patients were 
performed with PET by several investigators. In 
OCD patients, CMR was significantly elevated in 
the left orbital gyrus and bilaterally in the caudate in 
comparison to normals and depressives. Left orbital 
gyrus CMR was increased significantly and right 
orbital gyrus non-significantly in OCD in com-
parison to the other two groups. Successful treat-
ment did not alter this finding. Caudate CMR 
increased with treatment with a number of drugs in 
responders but not in non-responders (Baxter et aL 
1987). The same investigators performed a second 
study with improved methodology. CMR glucose 
for the entire cerebral hemispheres, heads of the 
caudate and orbital gyri were higher in patients with 
OCD as compared to normal controls. Both left and 
right orbital gyri showed significant elevations in 
patients (Baxter et al, 1988). Nordahl and associates 
(1989) compared eight non-depressed OCD patients 
with thirty normal volunteers. Orbital CMR was 
high in OCD patients; however, caudate metabolism 
was same in patients and controls. Right parietal and 
left occipital-parietal regions were higher in normals 
than in the patients. The investigators did not study 
whole brain CMR. 
Swedo and associates (1989) studied CMR 
glucose with PET in nine men and nine women with 
childhood onset OCD. The OCD group showed in-
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creased CMR glucose in left orbital and right sen-
sorimotor regions and bilaterally in anterior cingu-
late gyri and prefrontal areas. Ratios of regional to 
mean cortical CMR were increased for the right 
prefrontal and left anterior cingulate regions in the 
patient group. A significant correlation was ob-
served between right orbital CMR and OCD 
severity. Six patients who failed to respond to 
clomipramine had significantly higher right anterior 
cingulate and right orbital CMR as compared to the 
responders. State anxiety during CMR measurement 
correlated significantly with right prefrontal, left 
prefrontal and right orbital CMR expressed as ratios 
to the mean cortical CMR. OCD patients who 
panicked during the scan revealed significantly 
lower left premotor CMR and higher right prefrontal 
CMR; the latter was expressed as a ratio to mean 
cortical CMR. 
Martinot and associates (1990) found results 
quite different from the other studies. They found 
lower CMR glucose in all brain regions in sixteen 
OCD patients as compared to eight controls. Lateral 
prefrontal cortex (expressed as a ratio to global 
CMR) was significantly lower in OCD patients. No 
abnormalities were found in orbital CMR. Another 
CMR glucose study was performed on ten OCD 
patients with depression, twelve OCD patients 
without depression, six manics, ten unipolar and ten 
bipolar depressives and twelve controls. OCD with 
major depression was distinguished from the non-
depressed OCD state by decreased left dorsal 
anterolateral prefrontal glucose metabolic rates. 
Lower CMR in left dorsal anterolateral prefrontal 
cortex characterized unipolar and bipolar depres-
sives as well (Baxter et aL 1989). 
Benkelfat and coworkers (1990) examined CMR 
glucose in eight OCD patients after an average of 
sixteen weeks of treatment with clomipramine. 
Regardless of the change in clinical status, CMR 
decreased in orbital cortex and left caudate sig-
nificantly. Right anterior putamen showed increase 
in CMR. Good responders showed significantly 
more marked decrease in left caudate than non-
responders. No other brain region showed any sig-
nificant change. CMR glucose measurements were 
repeated in thirteen OCD patients by Swedo and 
associates (1992), after clomipramine, fluoxetine 
and no drugs after an average of twenty months. In 
responders, orbito-frontal CMR (expressed as a ratio 
to global CMR) decreased significantly on both 
sides. Among the treated patients, the right or-
bitofrontal metabolism decrease correlated with two 
measures of OCD improvement. Baxter and col-
leagues (1992) studied ten OCD patients before and 
after treatment with either fluoxetine alone or be-
havioral treatment. In both groups, right caudate 
CMR decreased significantly in treatment 
responders but not in non-responders. Percentage 
change in right caudate CMR correlated with per-
centage change in the obsessive compulsive disorder 
severity significantly in the fluoxetine group and 
non-significantly in the behavioral therapy group. 
Right anterior cingulate gyrus and left thalamus 
decreased with fluoxetine but not with behavioral 
modification (Baxter et aL 1992). 
Azari and associates (1993) performed a multiple 
regression / discriminant analysis of CMR glucose 
in ten OCD patients before and during phar-
macotherapy. Before therapy, a discriminant func-
tion reflecting parietal, sensory-motor and 
mid-brain CMR glucose interdependencies correct-
ly classified eighty percent of the patients; after 
therapy seventy percent were classified as controls, 
most of whom were responders. Before therapy, 
CMR glucose interdependencies involving basal 
ganglia, thalamus, limbic and sensory and associa-
tion cortical regions distinguished sixty seven per-
cent of responders and seventy five percent of 
non-responders. After therapy, all responders were 
classified as controls; classification of non-
responders remained unchanged. 
Horwitz and associates (1991) computed correla-
tions between regional CMR in eighteen OCD 
patients. The two regions that had the largest number 
of correlations that differed significantly between 
groups (OCD patients and controls) were left hemi-
sphere superior parietal region and left hemisphere 
anterior medial temporal area including amygdala. 
Correlations involving the caudate did not differ 
between the groups for most part. Anterior limbic / 
paralimbic regions had correlations in the OCD 
group that were significantly larger with frontal 
areas than in controls, and correlations that were 
significantly smaller with posterior brain regions. 
This pattern was especially pronounced for the left 
hemisphere anterior medial temporal regions. 
Patients with obsessional slowness exhibit ex-
treme slowness in the execution of some everyday 
tasks such as washing and eating. This may be due 
to time consuming rituals, checking behavior and 
compulsions. Sawle and associates (1991) studied 
six patients with obsessional slowness with PET-
CMR oxygen (regional cerebral oxygen metabo-
lism) and presynaptic nigrostriatal system integrity. 
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Figure 3 
The Inverted U relationship between 




Optimum performance occurs with moderate 
anxiety levels, less or more anxiety cause 
deterioration. Mild anxiety is also associated 
with CBF increase, with more severe anxiety 
being associated with CBF decrease. Thus, 
there seem to be inverted U relationships be-
tween anxiety and both performance and CBF. 
The findings were of focal hypermetabolism in or-
bital frontal pre-motor and midfrontal cortex while 
dopa ( F-dopa) uptake into caudate, putamen and 
medial frontal cortex was normal. More recently, 
Rauch and coworkers (1994) provoked obsessions 
in eight OCD patients with appropriate stimuli 
during CBF measurement with PET. OCD symptom 
activation resulted in significant increases in CBF to 
left anterior cingulate and bilateral orbito-frontal 
cortex. 
Trichotillomania (compulsive hair pulling) 
though classified under "Impulse Control Disor-
ders" in DSM-IIIR, resembles OCD to some degree. 
Ten females with this disorder showed a regional 
CMR glucose pattern very different from OCD 
patients. Trichotillomania patients showed sig-
nificantly increased global (grey matter), right and 
left cerebellar and right superior parietal CMR 
glucose. However, improvement after 
clomipramine treatment correlated inversely with 
anterior cingulate and orbital frontal metabolism 
similar to the findings from OCD patents treated 
with the same drug (Swedo ct al, 1991). 
Results of the CBF/CMR studies mentioned 
above implicate a wide variety of cerebral structures 
in OCD. Of the various brain regions identified, 
orbital prefrontal cortex and to a lesser extent, the 
caudate stand out. OCD seems to be associated with 
increased CMR glucose in these two brain regions 
which return to normality after successful treatment 
(Baxter, 1992). 
CONCLUSION 
Different anxiety related factors increase and 
decrease CBF. Nonspecific arousal mediated by the 
reticular activating system increase CBF while 
hypocapnia and sympathetic stimulation decrease 
CBF. The relationship between CBF and anxiety is 
complicated by the interplay of these cerebral 
vasodilatory and vasoconstrictive factors. Under 
resting conditions, when anxiety related 
vasoconstrictive factors are not activated, CBF 
seems to be highest in the frontal regions. Mild 
increases in arousal increase CBF globally and in the 
frontal regions, bilaterally. The same effect is seen 
with mild anxiety. More severe anxiety seem to be 
associated with CBF decrease. It must be noted that 
these findings of CBF increase during mild anxiety 
and decrease during severe anxiety are supported by 
many, but not all studies. 
CBF increase during mild anxiety is easy to ex-
plain on the basis of reticular activating system 
mediated arousal. Increase in brain activity is as-
sociated with parallel increases in CBF and CMR. 
CBF reduction during severe anxiety is more dif-
ficult to explain. Hypocapnia would seem to be the 
most likely explanation; however, several studies in 
which CO2 was measured and controlled for, could 
not explain the reduction in CBF on this basis. 
Anxiety related increase in sympathetic cerebral 
vasoconstrictive tone is another factor to be con-
sidered. Anxiety disorder patients have been shown 
to have higher sensitivity to sympathetic activation 
(Nesseetal, 1984).Thus, it wouldseem highly likely 
that sympathetic activation is the vasoconstrictive 
factor associated with severe anxiety. Sympathetic 
activation may also explain cerebral ischemic events 
associated with anxiety and panic (Coyle & Ster-
man, 1986; Mathew et al, 1987). Over sensitivity to 
sympathetic stimulation has been implicated in 
cerebral vasospasm associated with subarachnoid 
hemorrhage (Boullin, 1980; Rosenblum & Guilianti, 
1973). 
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According to the Yerkes-Dodson Law, "The op-
timum level of aversive stimulation in the control of 
learning is at some moderate intensity, lower and 
higher values being less effective; the optimum level 
decreases as task complexity increases" (Yerkes & 
Dodson, 1980; Hilgard et al, 1971). This would seem 
to indicate that moderate levels of anxiety facilitate 
performance, with higher levels having the opposite 
effect. More recent psychophysiological experi-
ments provided partial support for this inverted U 
relationship (Figure 3) between anxiety and perfor-
mance (Duffy, 19
72). A similar inverted U relation-
ship between anxiety and CBF/CMR is of 
considerable heuristic significance. 
However, it must be pointed out that a number of 
mechanisms protect the brain from anoxia and that 
the CBF has to fall below 20ml/100gm/minute for 
ischemic symptoms to occur (Lassen & Astrup, 
1987). Nobody has reported CBF below this level, 
even in severe anxiety. However, it must also be 
noted that panic attacks were associated with focal 
cerebral ischemia; unfortunately CBF measure-
ments were not available in studies by Coyle and 
Sterman (1986) and Mathew and associates (1987). 
There is not enough information to justify firm 
conclusions about the effects of anxiety and panic 
on flow and metabolism in different brain regions. 
Study of regional CBF and CMR is plagued by a 
number of technical problems. First of all, even the 
best currently available imaging techniques do not 
have the spacial resolution necessary to image small 
sub-cortical structures satisfactorily. Many of the 
studies were performed with techniques with poor 
spacial resolution. Identification of sulci which is 
necessary for the separation of cortical regions can 
be very difficult on tomographic slices. Most studies 
did not have the statistical power (number of par-
ticipants) necessary to identify regional differences. 
More studies with high resolution techniques need 
to conducted with larger numbers of participants. 
As was pointed out earlier, many CBF techniques 
do not provide absolute values; flow is ap-
proximated from the intensity of radioactivity 
registered from different brain regions (count rates). 
The assumption is that count rates represent the 
amount of radioisotope (tracer) delivered to that 
region via the blood circulation and therefore, they 
serve as an indices of blood flow. However, count 
rates will also be influenced by quantity of isotope 
injected, extravasation at the injection site, total 
blood volume, ratio of flow to the brain as compared 
to other tissues, blood brain partition coefficients, 
proximity of the region to the scintillation detector, 
intervening tissues between the region and the scin-
tillation detector, etc Regional count rates are ex-
pressed as a ratio of count rates from another region 
(reference region) or the entire brain. 
This approach rests on the assumption that the 
"reference brain region" will not show (anxiety re-
lated) CBF changes and that in that region, flow will 
remain stable across different measurements. Since 
anxiety is likely to change both regional as well as 
global CBF/CMR through a variety of mechanisms, 
circulation in no region (or the entire brain) can be 
considered to be silent during anxiety. Thus, the ratio 
technique is of questionable validity, especially in 
anxiety research. The assumption that regional flow 
(as opposed to global flow) is mainly an index of 
brain function is also weak. It also needs to be 
pointed out that sympathetic innervation of cerebral 
blood vessels show regional variations. Sympathetic 
stimulation has also been shown to influence CMR 
(Edvinsson et al, 1993). 
There seems to be general agreement that OCD 
may be associated with increased CBF and CMR in 
orbital frontal gyrus and perhaps, in the caudate. 
There is less agreement about the involvement of 
other brain regions. The effects of anxiety and 
depression of CBF/CMR in OCD patients deserve 
further study. 
Most of the available reports on CBF/CMR and 
anxiety are from normals, panic disorder patients 
and OCD patients. Patients with other anxiety disor-
ders have not been studied. In all probability, like 
OCD, other anxiety disorders may also be associated 
with specific regional abnormalities in CBF and 
CMR. 
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